Recent Updates on Indole Derivatives as Kinase Inhibitors in the Treatment of Cancer

Area of Science:

• Medicinal Chemistry
• Drug Discovery
• Oncology

Background:

• Cancer presents significant global health challenges, necessitating novel therapeutic strategies.
• Kinases are crucial targets for anticancer drug development due to their role in cell proliferation.
• Indole derivatives have emerged as effective scaffolds for targeting various kinases.

Approach:

• This review synthesizes structure-activity relationship (SAR) studies of indole derivatives as kinase inhibitors.
• It highlights recent research on indole-based inhibitors targeting specific kinases like PI3K and CDK5.
• The focus is on understanding how structural modifications influence inhibitory activity.

Key Points:

• Indole derivatives demonstrate broad-spectrum kinase inhibition, including PIM, CDK, TK, AKT, SRC, PI3K, PKD, and GSK.
• Specific substitutions on the indole ring, such as at the 4th, 2nd, and 6th positions, yield potent inhibitors.
• SAR studies are crucial for optimizing indole derivatives for anticancer efficacy.

Conclusions:

• Indole derivatives represent a promising class of compounds for developing novel anticancer therapies.
• Targeting multiple kinases with indole-based inhibitors offers a strategy to overcome cancer treatment challenges.
• Further SAR exploration will facilitate the design of more potent and selective kinase inhibitors for cancer treatment.